Want to know:
A young adult presents for reassessment of uncontrolled asthma symptoms. The patient is currently taking an inhaled short-acting beta2-agonist (SABA) as needed and reports daytime symptoms more than 3 days/week, but not daily, and nighttime awakenings 4 to 5 times/week. The patient's forced expiratory volume (FEV1) is 80% of predicted. The nurse practitioner upgrades the patient to the next stage of treatment, which includes:A. Budesonide with formoterolB. Budesonide with montelukastC. Cromolyn or nedocromilD. Fluticasone with salmeterol
Get a detailed, AI-powered explanation for this question and thousands more on StudyFetch.
Get the Answer for FreeHow StudyFetch Helps You Master This Topic
AI-Powered Answers
Get instant, detailed explanations powered by AI that understands your course material.
Deep Understanding
Go beyond surface-level answers with step-by-step breakdowns and examples.
Personalized Learning
Spark.E adapts to your learning style and helps you connect ideas.
Practice & Test
Turn any question into flashcards, quizzes, and practice tests to solidify your knowledge.
Explore More Questions
- L'être humain ne peux ni exister ni connaître le développement propre à son espèce comme un élément isolé, il a nécessairement ses prolongements dans autrui
- Which statement is FALSE regarding the causes behind the transition of land plants from water to land?
- For how long did Upton Sinclair work for the Chicago Stockyard company.